“Persisters”: Survival at the Cellular Level

1. BiggerJ 1944 Treatment of staphylococcal infections with penicillin. Lancet 244 497 500

2. LewisK 2007 Persister cells, dormancy and infectious disease. Nat Rev Micro 5 48 56

3. LewisK 2010 Persister cells. Ann Rev Microbiol 64 357 372

4. Al-DhaheriRSDouglasJ 2008 Absence of amphotericin B-tolerant persister cells in biofilms of some Candida species. Antimicrob Agents Chemother 52 1884 1887

5. KerenIKaldaluNSpoeringAWangYLewisK 2004 Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 230 13 18

6. LaFleurMDKumamotoCALewisK 2006 Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 50 3839 3846

7. LewisK 2008 Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 322 107 31

8. RobertsMEStewartPS 2005 Modeling protection from antimicrobial agents in biofilms through the formation of persister cells. Microbiol 151 75 80

9. KaernM 2005 Stochasticity in gene expression: from theories to phenotypes. Nat Rev Genet 6 451 464

10. JayaramanAWoodTK 2008 Bacterial quorum sensing: signals, circuits, and implications for biofilms and disease. Ann Rev Biomed Eng 10 145 167

11. Vazquez-LaslopNLeeHNeyfakhAA 2006 Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J Bacteriol 188 3494 3497

12. SchumacherMAPiroKMXuWHansenSLewisK 2009 Molecular mechanisms of HipA-mediated multidrug tolerance and its neutralization by HipB. Science 323 396 401

13. MillerCThomsenLEGaggeroCMosseriRIngmerH 2004 SOS response induction by beta-lactams and bacterial defense against antibiotic lethality. Science 305 1629 1631

14. DörrTVulićMLewisK 2010 Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol 8 e1000317 doi:10.1371/journal.pbio.1000317

15. LewisK 2001 Riddle of biofilm resistance. Antimicrob Agents Chemother 45 999 1007

16. KumamotoCA 2002 Candida biofilms. Curr Opin Microbiol 5 608 611

17. KerenIShahDSpoeringAKaldaluNLewisK 2004 Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 186 872 880

18. Jabra-RizkMAFalklerWAJrMeillerTF 2004 Fungal biofilms and drug resistance. Emerg Infect Dis 10 14 19

19. RedmondKMWilsonTRJohnstonPGLongleyDB 2008 Resistance mechanisms to cancer chemotherapy. Front Biosci 13 5138 5154

20. KurataTTamuraKKanedaHNogamiTUejimaH 2004 Effect of re-treatment with gefitinib after acquisition of resistance. Ann Oncol 15 173 174

21. YanoSNakatakiEOhtsukaSInayamaMTomimotoH 2005 Retreatment of lung adenocarcinoma patients with gefitinib who had experienced favorable results from their initial treatment with this selective epidermal growth factor receptor inhibitor: a report of three cases. Oncol Res 15 107 111

22. SharmaSVLeeDYLiBQuinlanMPTakahashiF 2010 A Chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141 69 80

23. GlasspoolRMTeodoridisJBrownR 2006 Epigenetics as a mechanism driving polygenic clinical drug resistance. Br J Cancer 94 1087 1092

24. FrankNSchattonTFrankMH 2010 The therapeutic promise of the cancer stem cell concept. J Clin Invest 20 41 50

25. BalabanNQMerrinJChaitRKowalikLLeiblerS 2004 Bacterial persistence as a phenotypic switch. Science 305 1622 1625